Novo Nordisk
NVO
#21
Rank
NZ$787.20 B
Marketcap
$173.42
Share price
-3.40%
Change (1 day)
3.94%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Market capitalization of Novo Nordisk (NVO)

Market cap: NZ$787.20 Billion

As of November 2024 Novo Nordisk has a market cap of NZ$787.20 Billion. This makes Novo Nordisk the world's 21th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Novo Nordisk from 1996 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$787.20 B7.94%
2023NZ$729.30 B52.06%
2022NZ$479.60 B28.43%
2021NZ$373.43 B65.23%
2020NZ$226.00 B9.41%
2019NZ$206.57 B23.93%
2018NZ$166.68 B-9.72%
2017NZ$184.63 B35.81%
2016NZ$135.95 B-38.9%
2015NZ$222.52 B54.81%
2014NZ$143.74 B16.73%
2013NZ$123.13 B11.36%
2012NZ$110.57 B29.38%
2011NZ$85.47 B-2.37%
2010NZ$87.54 B57.08%
2009NZ$55.73 B-0.73%
2008NZ$56.14 B2.48%
2007NZ$54.78 B45.47%
2006NZ$37.65 B41.29%
2005NZ$26.65 B5.55%
2004NZ$25.25 B16.07%
2003NZ$21.75 B13.17%
2002NZ$19.22 B-42.57%
2001NZ$33.47 B20.02%
2000NZ$27.89 B59.02%
1999NZ$17.54 B-4.11%
1998NZ$18.29 B-1.91%
1997NZ$18.65 B87.9%
1996NZ$9.92 B

End of Day market cap according to different sources

On Nov 16th, 2024 the market cap of Novo Nordisk was reported to be:

NZ$805.89 Billion
by Yahoo Finance info icon info icon
NZ$787.20 Billion
by CompaniesMarketCap info icon info icon
NZ$773.82 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$239.55 B-69.57%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.207 T 53.38%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$194.35 B-75.31%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$213.99 B-72.82%๐Ÿ‡ซ๐Ÿ‡ท France